Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Although patient involvement in research was not part of the program at the 12th CCBIO Annual Symposium, it is a topic CCBIO will give more attention to. We had a chat with a user representative who participated at the symposium, and who is also contributing in one of our research projects.
The 12th CCBIO Annual Symposium has recently taken place, with a program showcasing current cancer biomarker research. This was the final symposium in CCBIO’s 10-year period funded by the Research Council of Norway as a Centre of Excellence (CoE), however not the last. CCBIO will continue its core activities, maintaining what has become a strong cancer research network.
Although CCBIO this summer completes its 10-year appointment as Center of Excellence by the Research Council of Norway, the center will continue its activities, and so do all the research groups and collaborations that have been established through these years. It has been a privilege for the CCBIO leadership to follow these groups from the very beginning and watch them grow and now continue to... Read more
The 12th CCBIO Annual Symposium took place May 14-15, 2024, at Solstrand outside of Bergen in excellent weather, facilitating a radiant frame for networking and meetings in the sunshine during the breaks. The program showcased current cancer biomarker research as well as taking a step back considering global perspectives on cancer.
The Norwegian Society of Pathology celebrated the first 100 years with a symposium on Updates and Future of Pathology. The event was supported by CCBIO and also celebrated with a history book covering the Society and its activities through 1923-2023.
CCBIO PhD candidate Marta Espevold Hjelmeland in the Krakstad group spends the second year of her PhD program in Boston.
The regional health authority Helse Vest’s Research Award 2023 goes to Professor Lars Andreas Akslen and CCBIO for ground-breaking research on cancer biomarkers. Akslen has also been subject to another prestigious recognition this fall, as he was recently elected as member of the Academia Europaea.
Mari Kyllesø Halle received a frame allocation of NOK 8 million in the Researcher Projects 2023 call from the Norwegian Cancer Association, for the project "Decoding the Landscape of Cancer Vulnerabilities in high-risk Cervical Carcinomas to detect new treatment strategies." CCBIO is proud to see this CCBIO Masterclass alumna as a project leader for the first time.
Emmet McCormack will be part of the new COST Action IMMUNO-model, where a network of scientists involved in the development and implementation of preclinical models evaluating the response and toxicity induced by immunotherapies, is challenged to expand our knowledge in their mechanisms of action and improve the survival and quality of life of cancer patients.
Forsker Grand Prix took place in Bergen September 27, where nine young researchers were competing for Best Presenter, getting only four minutes to convey their research in front of an audience and three judges. Among the nine was CCBIO's and the Department of Clinical Science's PhD Candidate Christiane Helgestad Gjerde.
The 11th CCBIO Annual Symposium was this time enlarged with a generous time frame and two overnight stays, May 8-11, 2023. Although there was an option for online attendance, only 14 participants chose to attend online, and the rest of the total of 235 chose to enjoy the company of colleagues and the informal and mutually fertilizing scientific crosstalk in the breaks and the evenings.
This winter/spring, three of CCBIO's students got the opportunity to have research stays at different labs of the Vascular Biology Program in Boston, through CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Camilla Tvedt Ekanger, Medical Student Research Program student Amalie Bark Kvamme and PhD Candidate Ole Vidhammer Bjørnstad are now back... Read more
A simple blood test can contribute to earlier detection of cancer and provide valuable information about the tumor in a number of cancers. The technology behind liquid biopsies is still being tested, but will change the landscape in cancer diagnostics, says professor and CCBIO-partner Klaus Pantel.
In his opening lecture of the 2023 General Assembly at the Vatican City, UiB professor Roger Strand explored the role of ethics in converging technologies.
The research group of Professor Daniela Costea is currently engaged in a DIKU/NORPART funded collaboration project with partners in Tanzania, establishing immunohistochemistry for p16 as a method for more precise diagnostic of head and neck cancers (HNC). CCBIO has just had a visit from Tanzania, and Professor Costea has just returned from a 2 week stay in Dar Es Salaam where she worked with... Read more
The INTPART-II Flagship-course CCBIO907 Cancer-Related Vascular Biology took place in Bergen March 24th to March 31st 2023, with fortunate students from UiB and a couple of visiting students from abroad who got the opportunity to learn from and connect with excellent Harvard Medical School faculty on campus in Bergen.
CCBIO would like to highlight recent publications in high impact journals.
Nothing in biology makes sense except in the light of evolution. So what is the evolutionary meaning of cancer? What will it take to get rid of it? In this lecture, professor in medicine Jarle Breivik explores the evolutionary logic of cancer.

Pages